Event Session
How AI is Transforming Life Sciences: Balancing Innovation, IP and Data Risk
October 27, 2025 @ 4:30 PM EST
4:30 PM ET
October 27, 2025
How AI is Transforming Life Sciences: Balancing Innovation, IP and Data Risk
As artificial intelligence (AI) becomes integral to drug development, it brings both transformative opportunities and significant intellectual property (IP) risks, particularly in safeguarding confidential information and data. This panel will explore the cutting-edge uses of AI in the life sciences industry and how AI technologies intersect with intellectual property protections. This business-focused panel will explore key considerations for biopharma companies, including evaluating AI use cases through an IP lens, managing data rights, and addressing jurisdictional and regulatory challenges. The discussion will provide practical insights into strategies for protecting proprietary data and algorithms, mitigating risks, and ensuring compliance in the fast-evolving landscape of AI-driven drug development—all while fostering innovation.
SURVEY:
https://www.surveymonkey.com/r/How-AI-is-Transforming-Life-Sciences
As artificial intelligence (AI) becomes integral to drug development, it brings both transformative opportunities and significant intellectual property (IP) risks, particularly in safeguarding confidential information and data. This panel will explore the cutting-edge uses of AI in the life sciences industry and how AI technologies intersect with intellectual property protections. This business-focused panel will explore key considerations for biopharma companies,…
Session Speakers
Sponsors
